Androgen treatment and recovery of function following recurrent laryngeal nerve injury in the rat

Todd J. Brown, Gina N. Monaco, Brent J. Benscoter, Avinash V. Mantravadi, Lee M. Akst, Kathryn Jones, Eileen M. Foecking

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Purpose: To investigate the effects of the androgen testosterone propionate (TP), on regeneration of the recurrent laryngeal nerve (RLN) after unilateral crush injury using assessment of vocal fold mobility (VFM) as a measure of behavioral recovery. Methods: 48 adult male rats underwent standardized crush injury of left RLN and received treatment in the form of 2 silastic capsules containing TP or controls receiving a blank capsule (untreated). Direct laryngoscopic assessment of vocal cord mobility was performed before, immediately following and 1, 2, 3, 4, 5 or 6 weeks post injury. Results: Treatment with TP enhanced the recovery of full VFM following crush injury of the RLN compared to controls. There was statistically significant improvement in VFM seen at the 1 and 2 week time points (p < 0.05). By 4 weeks TP-treated rats displayed a 100% recovery of VFM function, compared to only 50% by the control group. Conclusions: TP enhances RLN functional recovery following a crush injury, which further supports its potential general applicability as a therapeutic agent in peripheral nerve injury.

Original languageEnglish
Pages (from-to)169-176
Number of pages8
JournalRestorative Neurology and Neuroscience
Volume31
Issue number2
DOIs
StatePublished - 2013

Fingerprint

Recurrent Laryngeal Nerve Injuries
Testosterone Propionate
Vocal Cords
Recovery of Function
Recurrent Laryngeal Nerve
Androgens
Capsules
Peripheral Nerve Injuries
Regeneration
Control Groups
Crush Injuries
Wounds and Injuries

Keywords

  • crush injury
  • recurrent laryngeal nerve
  • Testosterone propionate
  • vocal fold mobility

ASJC Scopus subject areas

  • Neurology
  • Developmental Neuroscience
  • Clinical Neurology

Cite this

Brown, T. J., Monaco, G. N., Benscoter, B. J., Mantravadi, A. V., Akst, L. M., Jones, K., & Foecking, E. M. (2013). Androgen treatment and recovery of function following recurrent laryngeal nerve injury in the rat. Restorative Neurology and Neuroscience, 31(2), 169-176. https://doi.org/10.3233/RNN-120287

Androgen treatment and recovery of function following recurrent laryngeal nerve injury in the rat. / Brown, Todd J.; Monaco, Gina N.; Benscoter, Brent J.; Mantravadi, Avinash V.; Akst, Lee M.; Jones, Kathryn; Foecking, Eileen M.

In: Restorative Neurology and Neuroscience, Vol. 31, No. 2, 2013, p. 169-176.

Research output: Contribution to journalArticle

Brown, Todd J. ; Monaco, Gina N. ; Benscoter, Brent J. ; Mantravadi, Avinash V. ; Akst, Lee M. ; Jones, Kathryn ; Foecking, Eileen M. / Androgen treatment and recovery of function following recurrent laryngeal nerve injury in the rat. In: Restorative Neurology and Neuroscience. 2013 ; Vol. 31, No. 2. pp. 169-176.
@article{c17097818cda4742a9cefaf837b7d1e0,
title = "Androgen treatment and recovery of function following recurrent laryngeal nerve injury in the rat",
abstract = "Purpose: To investigate the effects of the androgen testosterone propionate (TP), on regeneration of the recurrent laryngeal nerve (RLN) after unilateral crush injury using assessment of vocal fold mobility (VFM) as a measure of behavioral recovery. Methods: 48 adult male rats underwent standardized crush injury of left RLN and received treatment in the form of 2 silastic capsules containing TP or controls receiving a blank capsule (untreated). Direct laryngoscopic assessment of vocal cord mobility was performed before, immediately following and 1, 2, 3, 4, 5 or 6 weeks post injury. Results: Treatment with TP enhanced the recovery of full VFM following crush injury of the RLN compared to controls. There was statistically significant improvement in VFM seen at the 1 and 2 week time points (p < 0.05). By 4 weeks TP-treated rats displayed a 100{\%} recovery of VFM function, compared to only 50{\%} by the control group. Conclusions: TP enhances RLN functional recovery following a crush injury, which further supports its potential general applicability as a therapeutic agent in peripheral nerve injury.",
keywords = "crush injury, recurrent laryngeal nerve, Testosterone propionate, vocal fold mobility",
author = "Brown, {Todd J.} and Monaco, {Gina N.} and Benscoter, {Brent J.} and Mantravadi, {Avinash V.} and Akst, {Lee M.} and Kathryn Jones and Foecking, {Eileen M.}",
year = "2013",
doi = "10.3233/RNN-120287",
language = "English",
volume = "31",
pages = "169--176",
journal = "Restorative Neurology and Neuroscience",
issn = "0922-6028",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - Androgen treatment and recovery of function following recurrent laryngeal nerve injury in the rat

AU - Brown, Todd J.

AU - Monaco, Gina N.

AU - Benscoter, Brent J.

AU - Mantravadi, Avinash V.

AU - Akst, Lee M.

AU - Jones, Kathryn

AU - Foecking, Eileen M.

PY - 2013

Y1 - 2013

N2 - Purpose: To investigate the effects of the androgen testosterone propionate (TP), on regeneration of the recurrent laryngeal nerve (RLN) after unilateral crush injury using assessment of vocal fold mobility (VFM) as a measure of behavioral recovery. Methods: 48 adult male rats underwent standardized crush injury of left RLN and received treatment in the form of 2 silastic capsules containing TP or controls receiving a blank capsule (untreated). Direct laryngoscopic assessment of vocal cord mobility was performed before, immediately following and 1, 2, 3, 4, 5 or 6 weeks post injury. Results: Treatment with TP enhanced the recovery of full VFM following crush injury of the RLN compared to controls. There was statistically significant improvement in VFM seen at the 1 and 2 week time points (p < 0.05). By 4 weeks TP-treated rats displayed a 100% recovery of VFM function, compared to only 50% by the control group. Conclusions: TP enhances RLN functional recovery following a crush injury, which further supports its potential general applicability as a therapeutic agent in peripheral nerve injury.

AB - Purpose: To investigate the effects of the androgen testosterone propionate (TP), on regeneration of the recurrent laryngeal nerve (RLN) after unilateral crush injury using assessment of vocal fold mobility (VFM) as a measure of behavioral recovery. Methods: 48 adult male rats underwent standardized crush injury of left RLN and received treatment in the form of 2 silastic capsules containing TP or controls receiving a blank capsule (untreated). Direct laryngoscopic assessment of vocal cord mobility was performed before, immediately following and 1, 2, 3, 4, 5 or 6 weeks post injury. Results: Treatment with TP enhanced the recovery of full VFM following crush injury of the RLN compared to controls. There was statistically significant improvement in VFM seen at the 1 and 2 week time points (p < 0.05). By 4 weeks TP-treated rats displayed a 100% recovery of VFM function, compared to only 50% by the control group. Conclusions: TP enhances RLN functional recovery following a crush injury, which further supports its potential general applicability as a therapeutic agent in peripheral nerve injury.

KW - crush injury

KW - recurrent laryngeal nerve

KW - Testosterone propionate

KW - vocal fold mobility

UR - http://www.scopus.com/inward/record.url?scp=84876356137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876356137&partnerID=8YFLogxK

U2 - 10.3233/RNN-120287

DO - 10.3233/RNN-120287

M3 - Article

VL - 31

SP - 169

EP - 176

JO - Restorative Neurology and Neuroscience

JF - Restorative Neurology and Neuroscience

SN - 0922-6028

IS - 2

ER -